Epicutantest-TROLAB[R]

Hauptinformation

  • Handelsname:
  • Epicutantest-TROLAB[R] D2415 Atropinsulfat 1% in Wasser
  • Darreichungsform:
  • Lösung
  • Zusammensetzung:
  • Atropinsulfat (Ph.Eur.) 1% (m/V)
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Epicutantest-TROLAB[R] D2415 Atropinsulfat 1% in Wasser
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • PEI.D.03045.01.1
  • Letzte Änderung:
  • 12-02-2018

13-4-2018

Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

Platelets with pH lower than 6.2 and a lack of “swirl” may not be viable. Transfusion of these platelets may lead to delayed correction of coagulopathy or low quality prophylactic platelet transfusion.

FDA - U.S. Food and Drug Administration

24-1-2018

Scientific guideline:  Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote reduction, refinement and replacement (3Rs) measures described in the European Pharmacopoeia - Applicable to veterina

Scientific guideline: Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote reduction, refinement and replacement (3Rs) measures described in the European Pharmacopoeia - Applicable to veterina

In accordance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a way as to use the minimum number of animals and to cause the least pain, suffering, distress or lasting harm. The European Pharmacopeia (Ph. Eur.) has, over the years, applied these principles by implementing alternative tests and assays that reduce, refine and replace animal use.

Europe - EFSA - European Food Safety Authority EFSA Journal

24-1-2018

Scientific guideline:  Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote replacement, reduction, and refinement (3Rs) measures described in the European Pharmacopoeia - Applicable to human v

Scientific guideline: Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote replacement, reduction, and refinement (3Rs) measures described in the European Pharmacopoeia - Applicable to human v

In accordance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a way as to use the minimum number of animals and to cause the least pain, suffering, distress or lasting harm. The European Pharmacopeia (Ph.Eur.) has, over the years, applied these principles by implementing alternative tests and assays that replace, reduce and refine animal use.

Europe - EFSA - European Food Safety Authority EFSA Journal

17-11-2017

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

The use of this product in patients with uncontrolled diarrhea due to chronic medical conditions may predispose the patient to toxicity from either the diphenoxylate or atropine components. Posted 11/17/2017

FDA - U.S. Food and Drug Administration

17-11-2017

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets

For Immediate Release – PEAPACK, NJ, November 16, 2017 - Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the potential to be super potent or sub potent.

FDA - U.S. Food and Drug Administration

30-10-2017

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

FDA - U.S. Food and Drug Administration

30-4-2018

ATROPINE SULFATE Injection, Solution [Patterson Veterinary]

ATROPINE SULFATE Injection, Solution [Patterson Veterinary]

Updated Date: Apr 30, 2018 EST

US - DailyMed

19-4-2018

ATROPINE SULFATE Injection, Solution [Fresenius Kabi USA, LLC]

ATROPINE SULFATE Injection, Solution [Fresenius Kabi USA, LLC]

Updated Date: Apr 19, 2018 EST

US - DailyMed

3-4-2018

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Solution [Lohxa]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Solution [Lohxa]

Updated Date: Apr 3, 2018 EST

US - DailyMed

27-3-2018

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [RedPharm Drug, Inc.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [RedPharm Drug, Inc.]

Updated Date: Mar 27, 2018 EST

US - DailyMed

13-3-2018

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Mylan Pharmaceuticals Inc.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Mylan Pharmaceuticals Inc.]

Updated Date: Mar 13, 2018 EST

US - DailyMed

2-3-2018

ATROPINE SULFATE Injection, Solution [Medical Purchasing Solutions, LLC]

ATROPINE SULFATE Injection, Solution [Medical Purchasing Solutions, LLC]

Updated Date: Mar 2, 2018 EST

US - DailyMed

2-3-2018

ATROPINE SULFATE Injection [Medical Purchasing Solutions, LLC]

ATROPINE SULFATE Injection [Medical Purchasing Solutions, LLC]

Updated Date: Mar 2, 2018 EST

US - DailyMed

1-2-2018

01.02.2018: Glivec 100 mg, Filmtabletten (teilbar), 60 Tablette(n), 1328.40, -23.3%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer56395002 ZulassungsinhaberNovartis Pharma Schweiz AGNameGlivec 100 mg, Filmtabletten (teilbar)Registrierungsdatum24.09.2003Original/GenerikumOriginalErstzulassung Sequenz24.09.2003ATC-KlassierungImatinib (L01XE01)Revisionsdatum15.09.2004WHOWHO-DDDGültig bis23.09.2018Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungZytostatikumPh+ chroni...

ODDB -Open Drug Database

1-2-2018

01.02.2018: Glivec 400 mg, Filmtabletten (teilbar), 30 Tablette(n), 2592.85, -23.0%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer56395006 ZulassungsinhaberNovartis Pharma Schweiz AGNameGlivec 400 mg, Filmtabletten (teilbar)Registrierungsdatum24.09.2003Original/GenerikumOriginalErstzulassung Sequenz16.01.2009ATC-KlassierungImatinib (L01XE01)Revisionsdatum15.09.2004WHOWHO-DDDGültig bis23.09.2018Index Therapeuticus (BSV)07.16.10.Packungsgrösse30 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungZytostatikumPh+ chroni...

ODDB -Open Drug Database

23-1-2018

ATROPINE SULFATE Injection, Solution [A-S Medication Solutions]

ATROPINE SULFATE Injection, Solution [A-S Medication Solutions]

Updated Date: Jan 23, 2018 EST

US - DailyMed

12-1-2018

ATROPINE SULFATE Injection, Solution [Cardinal Health]

ATROPINE SULFATE Injection, Solution [Cardinal Health]

Updated Date: Jan 12, 2018 EST

US - DailyMed

8-1-2018

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Proficient Rx LP]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Proficient Rx LP]

Updated Date: Jan 8, 2018 EST

US - DailyMed

1-1-2018

01.01.2018: Sprycel 20 mg, Filmtabletten, 60 Tablette(n), 1952.30, -17.1%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658001 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 20 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz02.02.2007ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myeloisc...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Sprycel 50 mg, Filmtabletten, 60 Tablette(n), 4159.45, -16.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658002 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 50 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz02.02.2007ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myeloisc...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Sprycel 70 mg, Filmtabletten, 60 Tablette(n), 4159.45, -16.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658003 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 70 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz02.02.2007ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myeloisc...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Sprycel 100 mg, Filmtabletten, 30 Tablette(n), 4268.05, -16.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658010 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 100 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz04.12.2009ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse30 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myelois...

ODDB -Open Drug Database

22-12-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [REMEDYREPACK INC.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [REMEDYREPACK INC.]

Updated Date: Dec 22, 2017 EST

US - DailyMed

21-12-2017

ISOPTO ATROPINE (Atropine Sulfate) Solution [Alcon Laboratories, Inc.]

ISOPTO ATROPINE (Atropine Sulfate) Solution [Alcon Laboratories, Inc.]

Updated Date: Dec 21, 2017 EST

US - DailyMed

21-12-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Solution [Atlantic Biologicals Corps]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Solution [Atlantic Biologicals Corps]

Updated Date: Dec 21, 2017 EST

US - DailyMed

15-12-2017

ATROPINE SULFATE Injection [General Injectables Vaccines, Inc]

ATROPINE SULFATE Injection [General Injectables Vaccines, Inc]

Updated Date: Dec 15, 2017 EST

US - DailyMed

7-12-2017

ATROPINE (Atropine Sulfate) Solution/ Drops [Akorn, Inc.]

ATROPINE (Atropine Sulfate) Solution/ Drops [Akorn, Inc.]

Updated Date: Dec 7, 2017 EST

US - DailyMed

22-11-2017

ATROPINE SULFATE Injection, Solution [REMEDYREPACK INC.]

ATROPINE SULFATE Injection, Solution [REMEDYREPACK INC.]

Updated Date: Nov 22, 2017 EST

US - DailyMed

16-11-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Lannett Company, Inc.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Lannett Company, Inc.]

Updated Date: Nov 16, 2017 EST

US - DailyMed

2-11-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Greenstone LLC]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Greenstone LLC]

Updated Date: Nov 2, 2017 EST

US - DailyMed

22-8-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [NuCare Pharmaceuticals,Inc.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [NuCare Pharmaceuticals,Inc.]

Updated Date: Aug 22, 2017 EST

US - DailyMed

10-8-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [PD-Rx Pharmaceuticals, Inc.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Aug 10, 2017 EST

US - DailyMed

3-8-2017

ATROPINE SULFATE Injection, Solution [General Injectables Vaccines, Inc.]

ATROPINE SULFATE Injection, Solution [General Injectables Vaccines, Inc.]

Updated Date: Aug 3, 2017 EST

US - DailyMed

31-7-2017

ATROPINE SULFATE Injection, Solution [Hospira, Inc.]

ATROPINE SULFATE Injection, Solution [Hospira, Inc.]

Updated Date: Jul 31, 2017 EST

US - DailyMed

18-7-2017

ATROPINE SULFATE Injection, Solution [American Regent, Inc.]

ATROPINE SULFATE Injection, Solution [American Regent, Inc.]

Updated Date: Jul 18, 2017 EST

US - DailyMed

20-6-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [ANI Pharmaceuticals, Inc.]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [ANI Pharmaceuticals, Inc.]

Updated Date: Jun 20, 2017 EST

US - DailyMed

16-6-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Atlantic Biologicals Corps]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Atlantic Biologicals Corps]

Updated Date: Jun 16, 2017 EST

US - DailyMed

15-6-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Unit Dose Services]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Unit Dose Services]

Updated Date: Jun 15, 2017 EST

US - DailyMed

23-5-2017

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Bryant Ranch Prepack]

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Tablet [Bryant Ranch Prepack]

Updated Date: May 23, 2017 EST

US - DailyMed